LB Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	250.17	22.98	14.98	21.4
Short-Term Investments	45.04	5.02	28.31	-
Cash & Short-Term Investments	295.21	28	43.29	21.4
Cash Growth	954.37%	-35.32%	102.26%	-
Prepaid Expenses	2.46	0.46	2.34	0.08
Other Current Assets	10.76	0.42	0.01	0.01
Total Current Assets	308.43	28.88	45.63	21.49
Property, Plant & Equipment	3.73	4.16	0.02	0
Other Long-Term Assets	0.77	0.5	-	-
Total Assets	312.93	33.53	45.66	21.49
Accounts Payable	2.13	2.32	1.39	0.16
Accrued Expenses	4.59	5.3	1.22	0.31
Current Portion of Leases	0.73	0.49	-	-
Total Current Liabilities	7.44	8.11	2.61	0.47
Long-Term Debt	-	-	-	24.15
Long-Term Leases	2.84	3.22	-	-
Other Long-Term Liabilities	1.34	2.5	1.56	18.49
Total Liabilities	11.62	13.83	4.16	43.11
Common Stock	0	0	0	0
Additional Paid-In Capital	430.67	9.66	6.47	6.13
Retained Earnings	-129.53	-104.32	-41.22	-34.95
Comprehensive Income & Other	0.17	0.11	0.27	-
Total Common Equity	301.31	-94.55	-34.47	-28.81
Shareholders' Equity	301.31	19.71	41.49	-21.62
Total Liabilities & Equity	312.93	33.53	45.66	21.49
Total Debt	3.57	3.7	-	24.15
Net Cash (Debt)	291.64	24.3	43.29	-2.74
Net Cash Growth	1100.38%	-43.88%	-	-
Net Cash Per Share	36.25	67.82	173.44	-11.87
Filing Date Shares Outstanding	28.67	0.25	0.25	0.23
Total Common Shares Outstanding	25.3	0.25	0.25	0.23
Working Capital	300.99	20.77	43.03	21.02
Book Value Per Share	11.91	-375.53	-138.11	-124.68
Tangible Book Value	301.31	-94.55	-34.47	-28.81
Tangible Book Value Per Share	11.91	-375.53	-138.11	-124.68
Machinery	0.51	0.47	0.03	0.01
Leasehold Improvements	1.49	1.49	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.